ARCHIVES

Reviewers Note Major Flaws In Design Of Burzynski’s Trials

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

Survival After Liver Transplant Called Excellent In Study

November 28, 2003

NMP22 Assay More Effective Than Conventional Lab Test

January 27, 2006

Charles Moertel, Mayo Clinic Investigator, Advocate Of Rigorous Trials, Dead At 66

July 8, 1994

NCI Payline In 1985 Likely To Be 170; $5.9 Million To Be Diverted to AIDS

December 7, 1984

In Brief: NCI To File Heroin IND For Pain Control; Sen. Cranston To Keynote Meeting On Centers

March 31, 1978

Roswell Park Wins $2.8 Million Grant

July 31, 2009